In the past few years, the united kingdom has witnessed a revolution in medical excess weight‑loss treatments — in the introduction of semaglutide (Wegovy®) to the rising reputation of tirzepatide (Mounjaro®). Now, An additional title is drawing awareness in both of those medical and public healt